Clinical Trials on Carbohydrate&Lipid Metabolism in Finland

Total 1258 results

University of South Florida
National Institute of Allergy and Infectious Diseases (NIAID); National Institute... and other collaborators

Recruiting

TrialNet Pathway to Prevention of T1D

Diabetes Mellitus, Type 1

United States, Australia, Canada, Finland, Italy, United Kingdom
Kuopio University Hospital
Turku University Hospital; Helsinki University Central Hospital; Oulu University... and other collaborators

Unknown

A Study of Surgical Weight Loss to Treat Obstructive Sleep Apnea

Obesity | Obstructive Sleep Apnea

Finland
AstraZeneca

Terminated

ARMOR (Analyzing Renal Mechanisms of Creatinine Excretion in Patients On tesaglitazaR)

Diabetes Mellitus, Type 2

United States
Hoffmann-La Roche

Completed

A Dose-Titration Study of GK Activator (2) in Patients With Type 2 Diabetes.

Diabetes Mellitus Type 2

United States, Estonia, Latvia, Mexico
Orion Corporation, Orion Pharma

Completed

Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC) (COMPOC)

Parkinson's Disease

Finland, Germany, Hungary, Latvia
Indiana University
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes (iGDM)

Pregnancy, High Risk | Overweight and Obesity | Gestational Diabetes

United States
Novo Nordisk A/S

Completed

Research Study Looking at How Well Semaglutide Works in People Living With Obesity and Prediabetes (STEP 10)

Obesity

United Kingdom, Canada, Denmark, Finland, Spain
Andromeda Biotech Ltd.

Completed

Efficacy Study of DiaPep277 in Newly Diagnosed Type 1 Diabetes Patients (DIA-AID)

Type 1 Diabetes

France, Italy, United Kingdom, Israel, South Africa, Spain, Austria, Czech Republic, Finland, Germany, Greece
Novo Nordisk A/S

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Malaysia, Australia, Taiwan, Thailand, Hong Kong, Singapore, Philippines
Pfizer

Completed

Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

Infections, Meningococcal

Finland
University of Helsinki
Royal Children's Hospital; Murdoch Childrens Research Institute; University of... and other collaborators

Active, not recruiting

Healthcare Transition of Adolescents With Chronic Health Conditions

Liver Diseases | Kidney Diseases | Diabetes | Rheumatic Diseases | Inflammatory Bowel Diseases | Neurologic Disorder | Congenital Heart Disease | Transition

Australia, Finland
Swedish Orphan Biovitrum

Completed

Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care (OPAL)

Hereditary Tyrosinemia, Type I

Belgium, Denmark, France, Germany, Austria, Czechia, Finland, Hungary, Ireland, Italy, Netherlands, Norway, Poland, Portugal, Spain, Sweden, United Kingdom
AstraZeneca
Astra Zeneca, Bristol-Myers Squibb

Completed

Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States, Netherlands, Canada
Novo Nordisk A/S

Completed

Biphasic Insulin Aspart 30 in Type 2 Diabetes Failing OAD Therapy (INITIATE)

Diabetes Mellitus, Type 2 | Diabetes

United States
Novo Nordisk A/S

Completed

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin (BEGIN™)

Diabetes Mellitus, Type 2 | Diabetes

United States, Spain, Denmark, Austria, Belgium, Serbia, Germany, Canada, France, Finland, Norway, Czech Republic
Diabetes Center of the Southwest
Solvay Pharmaceuticals

Withdrawn

Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes

Diabetes | Hypogonadism

United States
Boehringer Ingelheim

Completed

BI 10773 add-on to Metformin in Patients With Type 2 Diabetes

Diabetes Mellitus, Type 2

United States, Argentina, Austria, Czech Republic, Estonia, Finland, France, Germany, Hungary, Latvia, Norway, Romania, Russian Federation, Slovakia, Spain, Ukraine
Novo Nordisk A/S

Completed

Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

France, Denmark, Finland, Russian Federation, Macedonia, The Former Yugoslav Republic of, Hungary, Bulgaria, United Kingdom, Turkey, Poland, Czech Republic
Novo Nordisk A/S

Completed

Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Germany, France, Denmark, Sweden, Netherlands, Belgium, Finland, Macedonia, The Former Yugoslav Republic of, Norway, Israel, Spain, Croatia, Slovenia, United Kingdom, Switzerland, Ireland
Hospital Universitario Infanta Cristina

Unknown

The Titan Versus Everolimus Intracoronary Stent (Xience V) in Diabetic Patients (TITANIC-XV)

Diabetes Mellitus | Percutaneous Coronary Intervention

Spain, Finland
Fractyl Health Inc.

Recruiting

Evaluation of the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita® System in Subjects With Type 2 Diabetes on Insulin Therapy (REVITALIZE 1)

Type 2 Diabetes

United States, Ireland, United Kingdom, Belgium, Italy, Netherlands, Switzerland, Spain, France
Northwestern University
Massachusetts General Hospital; National Institute of Diabetes and Digestive... and other collaborators

Recruiting

Glycemic Observation and Metabolic Outcomes in Mothers and Offspring (GO MOMs)

Pregnancy Related | Gestational Diabetes

United States
Temple University
University of Pennsylvania

Unknown

Sleep Apnea in Look AHEAD (Action for Health in Diabetes)

Obstructive Sleep Apnea | Type 2 Diabetes

United States
Medtronic Diabetes

Completed

Use of the Guardian™ Connect System With Smart Connected Devices

Type 1 Diabetes Mellitus

United States
Novo Nordisk A/S

Completed

Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes (BOOST™)

Diabetes Mellitus, Type 2 | Diabetes

India, Denmark, Sweden, Malaysia, Poland, Turkey, Finland, Australia, Thailand, Taiwan
Boehringer Ingelheim

Completed

DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril

Hypertension | Diabetes Mellitus, Type 2

United Kingdom, Denmark, Finland, Netherlands, Norway, Sweden
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Galvus in Elderly Type 2 Diabetes Patients

Type 2 Diabetes Mellitus

United Kingdom, Belgium, Bulgaria, Spain, Slovakia, Germany, Finland
GlaxoSmithKline

Completed

Immunogenicity and Reactogenicity of a Booster Dose of GSK Bio's DTPa-HBV-IPV/Hib Vaccine

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

Finland
Novo Nordisk A/S

Completed

Comparison of Insulin Detemir Plus Insulin Aspart Against Insulin Glargine Plus Insulin Aspart in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

United States, Sweden, Finland, France, Norway
Solvay Pharmaceuticals

Completed

A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.

Patients With Metabolic Syndrome

Hungary, Canada, Finland, Italy, Netherlands, Norway, Poland, Romania, Sweden
CardioKine Inc.
Biogen; Cardiokine Biopharma, LLC

Completed

International, Multicenter Study of a Twenty-eight Week, Open-label, Titrated Oral Lixivaptan Administration in Patients With Chronic Hyponatremia: Extension to Studies CK-LX3401, 3405, and 3430

Hyponatremia With Excess Extracellular Fluid Volume | Hyponatremia With Normal Extracellular Fluid Volume

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of Age

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Haemophilus Influenzae Type b

Finland
Novo Nordisk A/S

Completed

Effect of Two Different Fasting Blood Glucose Targets on Glucose Control in Patients With Type 2 Diabetes Using Insulin Detemir Once Daily (TITRATE™)

Diabetes Mellitus, Type 2 | Diabetes

United States, Puerto Rico
Novo Nordisk A/S

Completed

Efficacy and Safety of Liraglutide Versus Lixisenatide as add-on to Metformin in Subjects With Type 2 Diabetes (LIRA-LIXI™)

Diabetes Mellitus, Type 2 | Diabetes

United Kingdom, France, Finland, Germany, Hungary, Latvia, Lithuania, Italy, Czech Republic
Shield Therapeutics

Recruiting

Evaluate the Safety and Efficacy of Ferric Maltol Oral Suspension vs. Ferrous Sulfate Oral Liquid in Children and Adolescents Aged 2 to 17 Years With Iron-deficiency Anaemia, With a Single Arm Study in Infants Aged 1 Month to Less Than 2 Years (FORTIS)

Iron-deficiency | Anemia

United States, United Kingdom, Puerto Rico
Bristol-Myers Squibb

Completed

Safety Study of BMS-770767 in Subjects With Type 2 Diabetes

Diabetes Type 2

United States, Canada, Korea, Republic of, Australia
Targacept Inc.

Completed

Glycemic Control, Safety and Tolerability of TC-6987 Monotherapy in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

United States
Novo Nordisk A/S

Completed

Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

United States, Puerto Rico
Novo Nordisk A/S

Terminated

To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c (LEAD-3)

Diabetes Mellitus, Type 2 | Diabetes

United States, Mexico, Puerto Rico
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

State-wide Health Approach to Increase Reach and Effectiveness: Study 1 (SHARE)

Obesity

United States
The Miriam Hospital

Completed

Behavioral Self-Regulation

Obesity

United States
The Miriam Hospital
National Heart, Lung, and Blood Institute (NHLBI)

Unknown

Modifying Obesogenic Homes: Impact on Weight Maintenance

Obesity

United States
Novo Nordisk A/S

Completed

Effect of Detemir and Sitagliptin on Blood Glucose Control in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

United States, Slovakia, Turkey, Canada, Finland, France, Hungary, Korea, Republic of
University of Prince Edward Island

Completed

The Effect of Wild Blueberry Consumption on Glucose Regulation in Healthy Adults

Diabetes

Canada
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Recruiting

Program for Fully Understanding Eating and Lifestyle Change (FUEL) (FUEL)

Obesity

United States
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

State-wide Health Approach to Increase Reach and Effectiveness: Study 3 (SHARE)

Obesity

United States
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

State-wide Health Approach to Increase Reach and Effectiveness: Study 2 (SHARE)

Obesity

United States
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Unknown

SPARK a Healthy and Fit Lifestyle (SPARK)

Obesity

United States
The Miriam Hospital

Recruiting

Weight Management Intervention in College: A Pilot Study

Obesity

United States
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Using Novel Behavioral Approaches to Improve Long-Term Weight Loss Outcomes

Obesity

United States

Clinical Trials on Carbohydrate&Lipid Metabolism in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations